Runny Nose as a Mounjaro Side Effect: What the Evidence Actually Shows

The misconception: Mounjaro causes cold-like symptoms as a known side effect

The biggest misunderstanding here is treating a runny nose as a predictable part of starting tirzepatide, on a par with nausea or constipation. It is not. The NHS patient information for tirzepatide sets out the recognised side-effect profile clearly, and upper-respiratory symptoms such as a runny or blocked nose do not appear in the common (affecting more than 1 in 100 people) or very common (more than 1 in 10) categories.

The licensed side-effect profile is led firmly by the gut. Nausea is the most frequently reported effect, and if you want to understand whether diarrhoea is a side effect of Mounjaro and how commonly it occurs, that is covered in detail separately. Vomiting, constipation, indigestion, and acid reflux also appear. Fatigue, headache, dizziness, and reactions at the injection site also appear. This profile reflects tirzepatide's dual action on GIP and GLP-1 receptors, both of which are involved in appetite signalling and the rate at which the stomach empties, not pathways associated with nasal secretion.

So if you are three days into your first pen and your nose is running, the honest answer is: that is almost certainly unrelated to the medicine. Colds circulate year-round, and the timing can feel suspicious when you have recently started something new. That said, the absence of a symptom from a listed profile does not make it impossible, and the right response is to mention it to your prescriber rather than dismiss it entirely.

Why some people connect nasal symptoms to their treatment, and what might genuinely be happening

There are a few reasons this link gets made. First, starting any new treatment prompts heightened body awareness; normal, coincidental symptoms get noticed and attributed. Second, GLP-1 and GIP receptors are present in tissues beyond the gut, including the airway, though the clinical significance of this for upper-respiratory symptoms in humans is not established in the trial data. Third, the nausea that many people experience after a dose increase can sometimes trigger post-nasal drip or increased mucus production as a secondary effect of repeated retching, not a direct pharmacological effect of tirzepatide itself.

The broader overview of Mounjaro side effects covers the full recognised spectrum, and it is worth reading that alongside the Patient Information Leaflet that arrives in the box with your pen. The pen itself is a pre-filled KwikPen; each contains four weekly doses. Tracking notes about symptoms in a simple log (what day, how severe, whether it coincided with a dose) gives your prescriber genuinely useful information if you raise it at your next review.

If your runny nose comes with nausea that is significant enough to affect eating and drinking, staying well-hydrated matters; persistent vomiting can put pressure on kidneys, and that is a conversation to have sooner rather than later. Practical support for nausea specifically is available, and our prescribers' guidance on nausea management covers what is and is not appropriate to take alongside tirzepatide.

When nasal or respiratory symptoms need medical attention

Most runny noses during Mounjaro treatment will resolve on their own and will turn out to be a coincidental viral infection. There are circumstances, though, where you should seek medical help rather than waiting.

Contact your GP or call 111 promptly if your nasal symptoms are accompanied by a high fever and significant difficulty breathing, or if you develop a severe sore throat alongside them and feel generally very unwell. These are not specific to tirzepatide, they are signs of a more significant infection that needs assessment regardless of what medicines you are taking. Tell whoever you speak to that you are on tirzepatide.

Separately, the MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known but infrequent serious risk with GLP-1 medicines. The symptom to watch for is severe stomach pain, sometimes reaching around to the back, that does not ease and may come with vomiting. That is distinct from nasal symptoms but worth knowing because it can be confused with a general unwellness. Get urgent medical help if that pattern fits.

For anything unexpected that does not fit the recognised side-effect profile, the Yellow Card scheme lets you report directly to the MHRA, your report contributes to ongoing safety monitoring and helps regulators spot patterns across the population taking these medicines.

How prescribers at nume handle side-effect concerns

Side-effect questions are not a distraction from the clinical process, they are part of it. At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber before any treatment is approved. That same clinical access continues after treatment starts: if something feels off, our team is available seven days a week.

For people already on tirzepatide wondering whether a symptom is connected to their dose, the detailed side-effect reference on this site covers each recognised effect with context on frequency and what to do. Symptoms such as hair thinning and frequent burping follow similar patterns, real in some people, often temporary, almost always manageable with clinical guidance.

If you are considering starting tirzepatide and want to discuss your specific health picture, including any conditions that might affect how you tolerate it, our prescribers work through that as standard. Start your free consultation and your questions about side effects can be addressed before any prescription is written.